Search

Your search keyword '"Leonards K"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Leonards K" Remove constraint Author: "Leonards K"
37 results on '"Leonards K"'

Search Results

1. 188P SAKK 16/14: Immune profiling of pre-operative biopsies correlates with survival and immune activation in stage IIIA (N2) NSCLC after neoadjuvant immunotherapy

2. EP16.01-018 SAKK 16/14 -Peripheral Immune Cell Populations Inresponse to Neoadjuvant Durvalumab in Patients with Stage IIIA(N2) NSCLC

3. MA12.04 SAKK 16/14: CD8 T Cell Positioning Correlates with Survivalin Stage IIIA(N2) NSCLC After Neoadjuvant Immunotherapy

4. MA09.02 SAKK 16/14 - T-Cell Receptor Repertoire Metrics Predict Response to Neoadjuvant Durvalumab in Patients With Stage IIIA(N2) NSCLC

6. PF449 INACTIVATION OF THE NUCLEAR INTERACTING SET DOMAIN PROTEIN 1 IMPAIRS GATA1-REGULATED TERMINAL ERYTHROID MATURATION AND INDUCES ERYTHROLEUKEMIA

8. Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer

11. Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia

14. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.

15. Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy.

16. Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology Consortium.

17. Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients.

18. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.

19. Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.

20. Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.

21. Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.

22. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.

23. Demonstration of potent lipid-lowering activity by a thyromimetic agent devoid of cardiovascular and thermogenic effects.

24. Roles of proteins in cation/membrane interactions of isolated rat cardiac sarcolemmal vesicles.

25. Isolation and characterization of large (0.5 - 1.0 micron) cytoskeleton-free vesicles from human and rabbit erythrocytes.

26. Electron spin resonance study of the isolated lipid components from Blastocladiella emersonii zoospores.

27. Effects of cations of the plasma membrane of Blastocladiella emersonii zoospores An ESR study.

28. A possible role of cholesterol in membrane adhesion.

29. Changes in the surface charge properties of isolated cardiac sarcolemmal vesicles measured by light scattering. II. Characteristics of rabbit preparations.

30. Coupling of Ca2+ transport to ATP hydrolysis by the Ca2+-ATPase of sarcoplasmic reticulum: potential role of the 53-kilodalton glycoprotein.

31. Electron microscopic study of the calcium phosphate-induced aggregation and membrane destabilization of cytoskeleton-free erythrocyte vesicles.

32. Potassium- and calcium-induced alterations in lipid interactions of isolated plasma membranes from blastocladiella emersonii. Evidence for an adenosine 5'-triphosphate requirement.

33. Monovalent cation-induced phospholipid vesicle aggregation: effect of ion binding.

34. Effects of proteins on phospholipid vesicle aggregation and lipid vesicle-monolayer interactions.

35. Roles of lipids and proteins in the Ca2+-PO4-induced aggregation of cytoskeleton-free erythrocyte vesicle membranes.

36. Changes in the surface charge properties of isolated cardiac sarcolemmal vesicles measured by light scattering. I. Characteristics of rat and canine preparations.

Catalog

Books, media, physical & digital resources